GlaxoSmithKline PLC ADR

Yahoo Finance • 3 months ago

GSK shares jump after landmark £1.68bn heartburn drug settlement

Shares in drugmaker GSK surged on Thursday after it struck a 2.2 billion US dollar (£1.68 billion) settlement to resolve tens of thousands of lawsuits in the US over its discontinued heartburn drug Zantac. The company said it had settled... Full story

Yahoo Finance • 3 months ago

GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement Deal, Stock Surges

GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement Deal, Stock Surges On Wednesday, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. st... Full story

Yahoo Finance • 3 months ago

Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)

Alector, Inc. --Participant baseline characteristics in INFRONT-3 suggest a representative study population that enables testing of the effects of latozinemab in frontotemporal dementia with a progranulin gene mutation (FTD-GRN)-- --Lato... Full story

Yahoo Finance • 3 months ago

GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults

GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults Wednesday, GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluat... Full story

Yahoo Finance • 5 months ago

GSK plc (GSK): Why Are Hedge Funds Bullish on This Undervalued UK Stock Now?

We recently compiled a list of the 10 Best Undervalued UK Stocks To Buy Now.In this article, we are going to take a look at where GSK plc (LON:GSK) stands against the other undervalued UK stocks. The Economy of the United Kingdom Accordi... Full story

Yahoo Finance • 5 months ago

Drugs firm GSK raises targets after strong cancer and HIV treatment sales

Drugs firm GSK (GlaxoSmithKline) has lifted its profits and sales growth targets for the year after a boost from cancer and HIV treatments. The firm’s boss, Emma Walmsley, hailed an “excellent second quarter performance”. The pharmaceuti... Full story

Yahoo Finance • 6 months ago

GSK Begins Shipping Influenza Vaccine Doses for 2024-25 Season

GSK supports annual flu immunization by getting FLULAVAL and FLUARIX to patients in advance of flu season PHILADELPHIA, July 11, 2024--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its trivalent... Full story

Yahoo Finance • 6 months ago

GSK plc (GSK): Is It the Best FTSE Dividend Stock to Buy According to Hedge Funds?

We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other FTSE dividend stocks. The first half of 2024 has been notable fo... Full story

Yahoo Finance • 6 months ago

GSK plc (GSK): Did This Healthcare Stock Show a Strong Performance in Q1?

We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other healthcare stocks under $50. If interested, you can also read... Full story

Yahoo Finance • 8 months ago

UPDATE 1-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

(Adds Pfizer comment in paragraph 3, context in paragraphs 4-6) By Blake Brittain April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to mes... Full story

Yahoo Finance • 8 months ago

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

By Blake Brittain (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccin... Full story

Yahoo Finance • 9 months ago

10 Best Weight Loss Drug Stocks to Buy Now

In this piece, we will take a look at the ten best weight loss drug stocks to buy now. If you want to skip our introduction to the rising weight loss drug industry and how it's one of the biggest trends on the stock market right now, then... Full story

Yahoo Finance • 9 months ago

Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?

If you're an individual investor who wants to invest like a billionaire fund manager, I've got good news. Following billionaires is relatively easy because the U.S. Securities and Exchange Commission makes anyone who manages over $100 mill... Full story

Yahoo Finance • 10 months ago

13 Best Pharma Dividend Stocks To Buy in 2024

In this article, we discuss 13 best pharma dividend stocks to buy in 2024. You can skip our detailed analysis of the pharma sector and its performance, and go directly to read 5 Best Pharma Dividend Stocks To Buy in 2024. Within the healt... Full story

Yahoo Finance • 10 months ago

GSK India arm's Q3 profit falls on government price cap

BENGALURU (Reuters) - GlaxoSmithKline Pharmaceuticals, the Indian unit of the UK's GSK, reported a 3% fall in third-quarter profit on Monday, hurt by the government's pricing cap on certain medicines. Consolidated profit before exceptiona... Full story

Yahoo Finance • 11 months ago

30 Most Valuable Drug Companies in 2024

In this article, we will take a look at the 30 most valuable drug companies in 2024. If you want to skip our detailed analysis of the pharmaceutical drugs market, you can go directly to 5 Most Valuable Drug Companies in 2024. The Global P... Full story

Yahoo Finance • 11 months ago

Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease

Alector, Inc. The trial, being conducted in partnership with GSK, is expected to enroll approximately 282 patients globally SOUTH SAN FRANCISCO, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC) and GSK plc (LSE/NYSE... Full story

Yahoo Finance • 11 months ago

GSK plc (NYSE:GSK) Q4 2023 Earnings Call Transcript

GSK plc (NYSE:GSK) Q4 2023 Earnings Call Transcript January 31, 2024 GSK plc misses on earnings expectations. Reported EPS is $0.72 EPS, expectations were $0.76. GSK isn't one of the 30 most popular stocks among hedge funds at the end of... Full story

Yahoo Finance • 11 months ago

GSK Upgrades Long-Term Outlook After Q4 Performance, Shingrix Vaccine And Newly Launched RSV Vaccine Shine

Wednesday, GSK Plc (NYSE:GSK) reported fourth-quarter adjusted operating profit of £1.75 billion, up 10% at the actual exchange rate (AER) and up 21% at the constant exchange rate (CER). The company’s RSV vaccine, Arexvy, hit £1.2 billion... Full story

Yahoo Finance • 11 months ago

Novo Nordisk Earnings Top Forecasts, Fueled by Ozempic, Wegovy Sales

**Novo Nordisk**, the maker of hit diabetes and weight-loss drugs **Ozempic** and **Wegovy**, reported quarterly sales and profit that [beat expectations](https://www.wsj.com/health/pharma/novo-nordisk-begins-gradually-increasing-supply-of... Full story